C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) A61K 39/12 (2006.01) C07K 14/015 (2006.01) C07K 14/02 (2006.01) C07K 14/03 (2006.01) C07K 14/035 (2006.01) C07K 14/045 (2006.01) C07K 14/05 (2006.01) C07K 14/06 (2006.01) C07K 14/065 (2006.01) C07K 14/07 (2006.01) C07K 14/11 (2006.01) C07K 14/12 (2006.01) C07K 14/125 (2006.01) C07K 14/145 (2006.01) C07K 14/15 (2006.01) C07K 14/155 (2006.01) C07K 14/16 (2006.01) C07K 14/175 (2006.01) C07K 14/18 (2006.01) C07K 14/33 (2006.01) C12N 7/01 (2006.01) C12N 15/863 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2105277
What is described is a modified vector, such as a recombinant poxvirus, particularly recombinant vaccinia virus, having enhanced safety. The modified recombinant virus has nonessential virus-encoded genetic functions inactivated therein so that virus has attenuated virulence. In one embodiment, the genetic functions are inactivated by deleting an open reading frame encoding a virulence factor. In another embodiment, the genetic functions are inactivated by insertional inactivation of an open reading frame encoding a virulence factor. What is also described is a vaccine containing the modified recombinant virus having nonessential virus-encoded genetic functions inactivated therein so that the vaccine has an increased level of safety compared to knwon recombinant virus vaccines.
Audonnet Jean-Christophe F.
Cox William I.
de Taisne Charles
Gettig Russell Robert
Johnson Gerard P.
Connaught Technology Corporation
Smart & Biggar
Virogenetics Corporation
LandOfFree
Genetically engineered vaccine strain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetically engineered vaccine strain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered vaccine strain will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1613375